GSTP1 rs1138272
|
Breast Cancer
|
GSTP1 rs1138272
|
Breast Cancer
|
docetaxel + cyclophosphamide Resistant: C3 – Early Trials
Breast Cancer Res Treat - 3 weeks (NewC3)
|
docetaxel + cyclophosphamide Resistant: C3 – Early Trials
Breast Cancer Res Treat - 3 weeks - (New C3)
|
GSTP1 rs1138272
|
Breast Cancer
|
GSTP1 rs1138272
|
Breast Cancer
|
docetaxel + epirubicin Resistant: C3 – Early Trials
Breast Cancer Res Treat - 3 weeks (NewC3)
|
docetaxel + epirubicin Resistant: C3 – Early Trials
Breast Cancer Res Treat - 3 weeks - (New C3)
|